General Information
Revision date
2011-02-07
Product name
ICP-OES Wavecal solution conc 500ml 50ppm
CAS No.
7697-37-2
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
Agilent Technologies, Inc
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
OSHA Hazards Physical state Liquid. Odor : Odorless. OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
Signal word
DANGER!
Hazard statements
CAUSES RESPIRATORY TRACT, DIGESTIVE TRACT, EYE AND SKIN BURNS. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Precautionary statements
Do not breathe vapor or mist. Do not ingest. Do not get in eyes or on skin or clothing. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation Corrosive to the respiratory system. Exposure to decomposition products may cause a
Health hazards
Serious effects may be delayed following exposure Ingestion Corrosive to the digestive tract. Causes burns. Skin Corrosive to the skin. Causes burns. Eyes Corrosive to eyes. Causes burns.
Potential chronic health
effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: lungs, mucous membranes, upper respiratory tract, skin, eye, lens or cornea, teeth, testes. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : Adverse symptoms may include the following: stomach pains Skin : Adverse symptoms may include the following: pain or irritation redness blistering may occur Eyes : Adverse symptoms may include the following: pain watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk aggravated by over- may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)